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Abstract 
Rationale. Gamma-hydroxybutyrate (GHB) is a putative neurotransmitter, a drug of 
abuse, an anesthetic agent and a treatment for neuropsychiatric disorders. In previous 
electroencephalography (EEG) studies, GHB was shown to induce an electrophysiological 
pattern of “paradoxical EEG-behavioral dissociation” characterized by increased delta and theta 
oscillations usually associated with sleep during awake states. However, no detailed source 
localization of these alterations and no connectivity analyses have been performed yet. 
Objectives and Methods. We tested the effects of GHB (20 and 35 mg/kg, p.o.) on 
current source density (CSD), lagged phase synchronization (LPS) and global omega 
complexity (GOC) of neuronal oscillations in a randomized, double-blind, placebo-controlled, 
balanced cross-over study in 19 healthy, male participants using exact Low Resolution 
Electromagnetic Tomography (eLORETA) of resting-state high-density EEG recordings. 
Results. Compared to placebo, GHB increased CSD of theta oscillations (5-7 Hz) in the 
posterior cingulate cortex (PCC) and alpha1 (8-10 Hz) oscillations in the anterior cingulate 
cortex. Higher blood plasma values were associated with higher LPS values of delta (2-4 Hz) 
oscillations between the PCC and the right inferior parietal lobulus. Additionally, GHB 
decreased GOC of alpha1 oscillations. 
Conclusion. These findings indicate that alterations in neuronal oscillations in the PCC 
mediate the psychotropic effects of GHB. Theta oscillations emerging from the PCC in 
combination with stability of functional connectivity within the default mode network might 
explain the GHB-related “paradoxical EEG-behavioral dissociation”. Our findings related to 
GOC suggest a reduced number of relatively independent neuronal processes, an effect that has 
also been demonstrated for other anesthetic agents. 
 
Keywords: Sodium oxybate, gamma-hydroxybutyric acid, source localization, lagged phase 
synchronization, global omega-complexity, EEG-behavioral dissociation, sedation 
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Introduction 
 Due to the depressant pharmacological effect of GHB on the central nervous system, 
early work focused on its use as an anesthetic agent (e.g., Appleton and Burn 1968; Laborit 
1964). The clinical use of GHB as general anesthetic is approved in Germany, Italy and France, 
even though its actual use is declining (Fuller et al. 2003). Moreover, sodium oxybate, a non-
proprietary synonym for GHB, gained attention in the psychiatric context because of its 
indication for the treatment of cataplexy in narcoleptic patients and its anxiolytic and 
antidepressant properties (Rinaldi et al. 1967; Bosch et al. 2012). Galloway and colleagues 
(2000) investigated illicit GHB use and reported its subjective central effects to be comparable 
to both alcohol and 3,4-methylenedioxymethamphetamine. The central effects range from 
drowsiness, euphoria and heightened sexuality to disinhibition and empathogenesis, which 
were recently addressed in an experimentally controlled study (e.g. Bosch et al. 2015).  
It has been argued that GHB fulfils the criteria for being categorized as a bona fide 
neurotransmitter (e.g., Vayer, Mandel, and Maitre 1987). Despite the fact that GHB has a high 
affinity for the recently discovered GHB receptor (Snead 2000), most of the behavioral effects 
of exogenously applied GHB seem to be mediated through the GABAB receptor, given that 
most effects of GHB were mimicked by a GABAB agonist (baclofen) or reduced by a GABAB 
antagonist (CGP 35348) (Nissbrandt and Engberg 1993). GHB is commonly administered 
orally and is absorbed rapidly within the gastro-intestinal tract. For dosages ranging from 
12.5mg/kg to 50mg/kg, peak plasma concentrations were reached after 20-60 minutes (Borgen 
et al. 2004; Ferrara et al. 1992; Liechti et al. 2016; Palatini et al. 1993). 
Because of the strong sedative properties of GHB, the similarity of GHB-induced brain 
states and sleep-induced states was recognized early on. According to Mamelak and colleagues 
(1977), sleep induced by GHB is not distinguishable from natural sleep in regard to subjectively 
reported effects as well as to its characteristic electroencephalography (EEG) pattern. In 
addition, the order of natural sleep stages, as measured by polysomnographic recordings, does 
not seem to be affected by GHB. One of the most replicated findings across studies is an 
increase of slow-wave sleep (SWS) and a decrease of non-rapid eye-movement sleep after the 
intake of GHB (Entholzner et al. 1995; Lapierre et al. 1990; Mamelak et al. 1977). 
Few studies, however, have explicitly examined the effect of GHB on electrophysiology 
of awake human subjects (Jimenez et al. 1982; Metcalf et al. 1966), although several studies 
have investigated the transition of the waking state to sleep or coma (Ducloux et al. 1989; 
Jenney et al. 1962; Orioli et al. 1966; Schneider et al. 1963). These studies consistently found 
a pattern referred to as “paradoxical EEG-behavioral dissociation”, characterized by an abrupt 
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shift from alpha to delta and theta rhythms during awake state, which is similarly observed 
during SWS. Thus, GHB seems to mimic the electrophysiological pattern of falling asleep, 
which is characterized by a shift of neuronal oscillations towards low frequencies, without being 
accompanied by actual loss of consciousness. The observed electrophysiological similarities of 
falling asleep with the effects of GHB could potentially explain the common sedating properties 
of the substance. However, the studies in which this “paradoxical EEG-behavioral dissociation” 
was found often lacked a placebo control group or an adequate randomization and blinding 
procedure.  
Here, we aimed to fill this knowledge gap using a double-blind placebo controlled 
design to investigate the effects of GHB on neuronal oscillations in awake humans. 
Furthermore, it is unclear in which brain areas these patterns of "paradoxical EEG-behavioral 
dissociation" emerge. Using state-of-the-art methods for source reconstruction, we quantified 
the effect of GHB on the current source density, lagged phase synchronization of neuronal 
oscillations and global omega complexity across brain areas. By identifying a neuronal correlate 
of the sedative effects of GHB, based on electrophysiological measurements, we contribute a 
valuable supplement to the knowledge about the sometimes contradictory pharmacological 
profile of the substance regarding its anesthetic properties. Based on the existing literature, we 
expected to replicate the dissociation between electrophysiology and behavior characterized by 
the emergence of low frequency waves without losing consciousness and to elucidate 
information about the localization and synchronization of the underlying neuronal generators.  
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Methods 
Participants. Twenty healthy, male participants (mean age 25.8±5.1 years) completed 
the study. In order to be included they had to fulfil the following criteria: (i.) male sex, (ii.) age 
within the range of 18 to 40 years, (iii.) absence of any somatic or psychiatric disorders, (iv.) 
no first-degree relatives with a history of psychiatric disorders, (v.) non-smoking, (vi.) without 
a history of drug abuse (lifetime use > 5 occasions, with exception of occasional cannabis use). 
None of the participants reported previous experiences with GHB in their life. Participants were 
instructed to abstain from alcohol for 24 hours before the session. Because the bioavailability 
of GHB is markedly reduced when taken together with food (Borgen et al. 2004), participants 
were asked to neither have breakfast nor drink caffeinated beverages on the morning of a testing 
session. Urine samples were collected on the two experimental days in order to ensure that all 
participants abstained from illegal substance use. All participants were instructed about 
potential risks concerning the administered substance and were compensated for the completion 
of the study. One subject had to be excluded prior to analysis because a majority of the EEG 
data was contaminated by strong artifacts. Thus, a remaining total of 19 subjects were included 
in the statistical analysis. 
General Procedure 
Permission. The study was approved by the Swissmedic and the Cantonal Ethics 
Committee of Zurich. Additionally the study was registered at ClinicalTrials.gov 
(NCT02342366) and, according to the declaration of Helsinki, all participants provided written 
informed consent.  
Study design. In order to investigate the pharmacological effects of GHB, a placebo-
controlled, randomized, balanced cross-over design was chosen. Every subject attended 4 
sessions: Screening, experimental day I, experimental day II and a follow-up session. 
Experimental days were separated by a washout phase of exactly seven days. 
Drug administration. Previous studies used dosages of GHB ranging from 10mg/kg 
(Grove-White and Kelman 1971) up to 72mg/kg (Abanades et al. 2006). For the present study 
every subject received one out of two different dosage levels, which comprised of 20mg/kg and 
35mg/kg GHB dissolved in 3dl of orange juice. These doses were chosen in line with existing 
literature indicating this range to produce subjective and cognitive alterations without causing 
unwanted side effects (e.g. Brenneisen et al. 2004; Palatini et al. 1993).  
Blood samples. The quantification of GHB in human plasma was performed according 
to the procedure of Meyer and colleagues (2011). Because blood samples were drawn 20 
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minutes before and 30 minutes after the EEG recording, the GHB plasma levels for a given 
time must be estimated. We used a straightforward approach, calculating the mean of the two 
surrounding measurements in order to create an appropriate estimation of each individual’s 
GHB plasma levels during the EEG recording. 
Subjective measurement. Acute subjective effects of the GHB administration were 
measured by a Visual Analog Scale (VAS). The dimensions general drug effect, sedation, 
stimulation and dizziness were assessed on a scale ranging from zero (“no effect”) to ten 
(“strong effect”). The VAS was issued at time points t – 15, + 40, + 60, + 100, + 120 and + 180 
minutes. 
Electroencephalogram recordings 
A BioSemi ActiveTwo electrode system (BioSemi, Netherlands) including 64 scalp 
electrodes was used to record EEG data during the period of plasma peak drug concentration. 
Horizontal and vertical eye movements were monitored by four additional electroocculogram 
electrodes. Electrophysiological signals were sampled at a rate of 2048 Hz. For detailed 
information about the preprocessing procedure see supplement. 
Current Source Density. To test drug effects on the electrophysiology of the brain, it is 
of specific interest to determine not only the topographic scalp map of the electrical currents, 
but also have an estimate of the underlying neuronal sources. Exact low-resolution brain 
electromagnetic topographic (eLORETA) (http://www.uzh.ch/keyinst/loreta.htm) was used to 
compute a three-dimensional EEG current source density map by applying a three-spherical 
shell model that restricts the solution space to grey matter and hippocampus, resulting in 6239 
different voxels (each 5mm x 5mm x 5mm). The head model used to compute the intracerebral 
current source density values was registered to the digitized MRI brain average of the Talairach 
and Tournoux atlas (Brain Imaging Centre, Montreal Neurological Institute). It must be noted 
that the assumption of synchronized discharge results in a high correlation of neighbouring 
voxels (Pascual-Marqui et al. 1994). 
The LORETA approach has been widely applied and has received numerous cross-
modal validations when combined with different encephalic activity localizing methods, such 
as functional, structural and diffusion spectrum magnetic resonance imaging, or positron 
emission tomography (Babiloni et al. 2011; Horacek et al. 2007; Mulert et al. 2005; Olbrich et 
al. 2009; Pizzagalli et al. 2004; Thatcher et al. 2012; Vecchio et al. 2015). eLORETA exerts 
several advantages over older versions because of its unbiased localization properties and 
 
 
7 
independence of the reference-choice (Jatoi et al. 2014; Pascual-Marqui 2007; Pascual-Marqui 
et al. 2011). 
In this study, a cross-registration between spherical and realistic head geometry was 
used in order to calculate the electrode coordinates (Towle et al. 1993). To compute spectral 
density (μA/mm2) the signal was split into six separate frequency bands: delta (2-4 Hz), theta 
(5-7 Hz), alpha1 (8-10 Hz), alpha2 (10-12 Hz), beta1 (13-20 Hz) and beta2 (20-30 Hz). 
Lagged Phase Synchronization. In addition to the examination of local neuronal activity, 
it is of specific interest to investigate how different regions integrate information in order to 
generate neural assemblies. Phase synchronization of neuronal oscillations is known to be a 
fundamental mechanism for enabling coordinated activity between spatially distinct brain 
regions (Uhlhaas and Singer 2010). Thus, numerous authors argue that the favorable and most 
studied approach for investigating large-scale integration of neuronal networks is phase 
synchronization (including Varela et al. 2001). Oscillatory synchronization represents a fast 
and efficient mechanism for communication between spatially distinct brain regions (Buzsáki 
and Draguhn 2004). Therefore, quantifying phase synchronization allows us to describe the 
physiological processes underlying non-linear functional connections between these distinct 
neuronal assemblies (Varela et al. 2001). 
In the present study, lagged phase synchronization as implemented in the eLORETA 
software was used to characterize altered functional connectivity between brain areas following 
the administration of GHB. This method has received cross-modal validation from diffusion 
tensor imaging (Vecchio et al. 2015) and fMRI (de Ridder et al. 2011). Accordingly, this 
method has been employed increasingly in recent studies (Canuet et al. 2011; Hilty et al. 2011; 
Kometer et al. 2015; Kühnis et al. 2014; Ramyead et al. 2015).  
Lagged phase synchronization allows us to calculate the functional connectivity 
between two regions of interest (ROI) for all previously defined frequency bands separately. In 
order to obviate a selection bias regarding the ROIs used for the further analysis, a whole-brain 
parcellation approach based on Brodmann areas was chosen (Pascual-Marqui et al. 2011). 
Accordingly, centroid voxels of all 42 Brodmann areas in both hemispheres were defined as 
ROIs, before computing all possible combinations of lagged phase synchronization between 
the ROIs (Canuet et al. 2011). 
Global Omega Complexity. In addition to analysis of the phase-synchronization 
between specific areas, analysis of coordinated activity across the entire scalp was quantified 
by the so-called global omega complexity index. Wackermann (1996) proposed a strategy for 
describing entire field-potential distributions by incorporating interpolated potential maps, 
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resulting in a single space-domain descriptor (see also Lehmann et al. 1987). The global omega 
complexity index can be used to assess the spatial synchronization over the entire scalp (Toth 
et al. 2009). Thus, it depicts the complexity of the trajectory in the K-dimensional state space 
(where K denotes the number of electrodes) by decomposing the signal into spatial principal 
components (Saito et al. 1998). High values of omega complexity are associated with high 
numbers of independent (neuronal) processes underlying the field-potential maps (Szelenberger 
et al. 1995). In other words, global omega complexity measures the degree of differentiation of 
a highly dynamic system and thereby reflects functional integration and specialization (Tononi 
and Edelman 1998). Global omega complexity has been shown to reflect mental states such as 
sleep or drug effects (Toth et al. 2012; Huber et al., 2006; Tononi and Edelman 1998; 
Szelenberger et al. 1995; Kondakor et al. 1999; Mölle et al. 1997). 
In order to compute global omega complexity the software eLORETA was used. All 
artifact-free segments derived from the 64 scalp electrodes were included, resulting in a single 
value for each previously defined frequency band for every condition (eyes-open placebo, eyes-
closed placebo, eyes-open GHB, eyes-closed GHB). The index was estimated against an 
average reference (Saito et al. 1998). 
Statistical analysis 
In order to analyze subjective evaluations of the drug effects as measured by the VAS and the 
GHB plasma values, a repeated measures (2*6) ANOVA was applied using the R project for 
statistical computing (Version 3.2.3) software. The time points (“time”) of the questionnaires 
and the conditions GHB vs. placebo (“drug”) were taken as factors. The regressors were 
calculated by subtracting the value of the placebo condition from the corresponding value of 
the GHB condition. If the main effect for the factor “drug” turned out to be significant, post hoc 
paired t-tests were applied for every time point. All p-values were corrected using the sequential 
rejective procedure from Holm (1979), which has been proven to be a powerful advancement 
of the Bonferroni algorithm (Hochberg and Benjamini 1990).  
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For calculating the statistical differences in electrophysiology between the conditions, a 
nonparametric mapping approach as implemented in the eLORETA software was used 
(Pascual-Marqui et al. 2011). Using a voxel-by-voxel-dependent t-test it was possible to 
calculate the contrast between the conditions for all frequency bands separately, while 
correcting for multiple comparisons across voxels and frequencies. Appropriate correction for 
multiple comparisons was achieved by applying a randomization strategy with 5000 
permutations. The possibility of detecting a dose-dependent effect by calculating placebo vs. 
high-dose and placebo vs. low-dose was not pursued for two reasons.  
 
First, as seen in Fig. 1 there was a considerable overlap in the GHB plasma levels between the 
two conditions. Therefore, it was not feasible to calculate contrasts based on different dosages 
of the drug. Second, when compared to other studies using a similar approach (e.g. Kometer et 
al. 2015) the sample size of the present study was moderate. Thus, in order to increase the 
statistical power for detecting a potential drug effect, the benefits of combining the two dosage 
levels were clear. 
Fig. 1 Scatterplot displaying GHB plasma values [nmol/mL] of each 
participant for the two dosage levels 25mg/kg (low dose) and 35mg/kg 
(high dose) for all time points, when blood withdrawal took place. 
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Additionally, the difference between placebo and GHB was correlated with the items of 
the VAS questionnaire and the estimated GHB plasma values at the given time point. That is, 
the difference between the GHB and the placebo condition was calculated and a voxel-wise 
product moment correlation was computed for each variable. We estimated the empirical 
probability distribution for the highest dependent sample t-values under the null hypothesis, 
when permutated 5000 times. Thus, it was not necessary to assume a Gaussian distribution for 
the dependent variable (Nichols and Holmes 2002) and an adequate correction for multiple 
comparisons across voxels and frequencies could be achieved. When computing the statistical 
significance for cortical voxels, the omnibus null hypothesis was rejected, as soon as at least 
one t value (two-tailed) reached the critical threshold for a significance level of p < .05. 
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Results 
GHB reached highest concentration in plasma at t + 35 min and went back to baseline 
levels at t + 190 min (see Figure 2). Repeated measures ANOVA (2*6) revealed significant 
main effects regarding the factor “drug” for GHB plasma values and all VAS items except for 
“stimulation” (see Table 1). The course of mean scores from all VAS items peaked at t + 35 
min, in close correspondence with GHB plasma concentrations (see Figure 3).  
 
  
Fig. 2 Mean (and standard error of mean) GHB plasma values in nmol/mL 
for all three dosage levels. Paired t-tests used for comparison of GHB with 
placebo condition: * p < .05, ** p < .01, *** p < .001. All p-values are 
corrected for multiple comparisons by Holm’s sequential rejective 
procedure. Time point of EEG recording is depicted in grey. 
E
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Current Source Density. When comparing placebo with GHB during eyes-closed 
condition, the current source density analysis for neuronal oscillations revealed statistically 
significant differences in the theta (5-7 Hz) and alpha1 (8-10 Hz) bands (see Fig. 4). In the theta 
band GHB significantly increased current source density values in 33 voxels, located in the 
posterior cingulate cortex (PCC) (22 voxels in BAs 23, 29, 30, 31), cingulate gyrus (10 voxels 
in BAs 23, 31) and precuneus (1 voxel in BA 31). The maximal increase in theta oscillations 
was found in the PCC (X = 5, Y = -45, Z = 25, t = -6.26, p = .006). In the alpha1 band GHB 
significantly increased current source density in 24 voxels, mainly located in the anterior part 
of the cingulate cortex (22 voxels in BAs 23, 24), as well as one voxel in the PCC (BA 23) and 
the insula (BA 13), respectively. The global maximum increase within the alpha1 band was 
located in the cingulate gyrus (X = -5, Y = -15, Z = 30, t = -6.11, p = .008). The differences of 
current source density between placebo and GHB were distributed almost symmetrically 
between the two hemispheres. Surprisingly, no statistically significant changes in any frequency 
band were found when contrasting placebo with GHB in the eyes-open condition, even though 
the strongest effects were consistently found in the theta (t = -4.12, p = .188) and the alpha1 
band (t = -4.30, p = .143). Additionally, the spatial distribution of the altered activity strongly 
overlapped with the eyes-closed condition (see Supplement). When correlating the GHB 
plasma values with the current source density difference of neuronal oscillations between 
placebo and GHB, no significant effects were found for the eyes-closed and the eyes-open 
condition.  
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Fig. 5 Statistical map of voxel-wise comparisons of current source density 
for all frequency bands in the eyes closed condition. Significantly 
increased voxels by GHB are depicted in yellow (p < .05). 
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Lagged Phase Synchronization. Analysis of lagged phase synchronization, when 
contrasting placebo with GHB, revealed no significant differences in any frequency band for 
both eyes-closed (pmax = .1608) and eyes-open (pmax = .9812) conditions. When correlating GHB 
plasma values with the lagged phase synchronization contrast between placebo vs. GHB, one 
connection was significantly increased in the eyes-open condition. As depicted in Fig. 5, the 
increased lagged phase synchronization value in the delta band (r > 0, p = .040) was found in 
the right hemisphere between the PCC (BA 29, X = 5, Y = -50, Z = 5) and the inferior parietal 
lobulus (BA 40, X = 50, Y = -30, Z = 45). During eyes-closed no significant difference was 
found (r > 0, pmax = .106). 
 
The regression analysis with subjective measures revealed one significant correlation. 
When correlating the lagged phase synchronization values with the VAS item “dizziness” a 
negative correlation (r < 0, p = .033) was found in the delta band between the precentral (BA 
4, X = -35, Y = -25, Z = 55) and the postcentral gyrus (BA 2, X = -55, Y = -25, Z = 50). 
Furthermore, at a trend level the score of the VAS item “stimulation” was negatively correlated 
with delta oscillations of lagged phase synchronization (r < 0, p = .058) between the PCC (BA 
29, X = -55, Y = -50, Z = 5) and the fusiform gyrus (BA37, X = 45, Y = -55, Z = -15).  
Global Omega Complexity. The administration of GHB compared to placebo during the 
eyes-open condition significantly decreased global omega complexity in alpha1 oscillations (p 
(a.) 
Fig. 5 (a.) Significantly increased connection of the GHB plasma regression affecting delta oscillations 
between the posterior cingulate cortex and inferior parietal lobulus from six different angles is depicted 
in black. (b.) Scatterplot of the relation between the LPS values for both conditions per participant of the 
connection depicted in (a.) and the GHB plasma values [nmol/L] in the eyes-open condition with a 
regression line with 95% confidence interval bar embedded. 
(b.) 
 
 
16 
= .0014). Furthermore, at a trend level global omega complexity in theta oscillations was found 
to be decreased as well (p = .061). All other frequency bands were not significantly affected by 
the effect of the drug (all p < .155). During eyes-closed none of the analyzed contrasts for each 
frequency band reached statistical significance. However, global omega complexity in theta 
oscillations showed a trend-level decrease for GHB compared to placebo (p = .066). 
Regression analysis of global omega complexity was performed, correlating all items 
of the VAS. Additionally, we computed the correlation of the drug-induced change of global 
omega complexity with GHB plasma values. Global omega complexity in both eyes-open and 
eyes-closed conditions correlated neither with subjective measures (r < 0, pmax = .388), nor with 
GHB plasma values (r < 0, pmax = .303). 
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Discussion 
In the present study, we assessed the pharmacological effect of GHB on current source 
density, lagged phase synchronization and global omega complexity of neuronal oscillations in 
comparison to placebo by means of electrophysiological neuroimaging. Signs of a “paradoxical 
EEG-behavioral dissociation”, which is characterized by slowing of oscillations during the 
awake state, could be partially replicated, as we found a concordant increase of theta oscillations 
after GHB administration. Additionally, we were able to observe a trend-level increase in delta 
oscillations induced by GHB. Previous studies used doses ranging from 35 mg/kg up to 63 
mg/kg, which could potentially have resulted in a stronger shift towards low frequencies, 
similar to the induction of sleep (Jenney et al. 1962; Metcalf et al. 1966). Additionally, we 
observed an increase in alpha1 oscillations, which is in line with the findings from Jimenez et 
al. (1982) but stands in contrast to the results from Metcalf et al. (1966), where the alpha 
frequency band mainly diminished during wakefulness. Given that Jimenez et al. (1982) used 
dosages up to 20 mg/kg and Metcalf et al. (1966) doses from 35 to 63 mg/kg, it is likely that 
the observed difference in alteration of alpha oscillations between these studies arises from the 
different dosage levels used. At the behavioral level, GHB induced subjective effects of 
sedation, stimulation, and dizziness, peaking at 40 minutes after the administration of the drug. 
In addition, the course of the “general drug effect” scale strongly corresponded to the course of 
GHB plasma levels, well reflecting the drug effect on a subjective level. 
We were able to complement the existing literature by adding information about the 
localization of the underlying neuronal sources generating the topographic map of electrical 
currents on the scalp. Our data suggest that GHB induced alterations of current source density 
are mainly located bilaterally in the cingulate cortex. Specifically, drug-induced changes of 
alpha oscillations were found in the ACC, which – among other functions – is a key region in 
the maintenance of an alert state (Posner & Rothbart, 1998). Interestingly, an increase of 
spatially coherent frontal alpha power has also been observed during the process of losing 
consciousness in healthy individuals anesthetized with propofol (Purdon et al. 2013). Thus, our 
findings may confirm the sedative properties of GHB and its use as an anesthetic agent by 
demonstrating electrophysiological similarities to another well-established anesthetic 
compound.  
The GHB-induced increase in current density of theta oscillations was most pronounced 
in the PCC, a major node within the default mode network (DMN) (Raichle 2015) with 
numerous structural connections to widespread regions of the brain (Leech et al. 2012). The 
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activity of the PCC has been proposed as a neuronal correlate of the level of consciousness. 
Vogt and Laureys (2005) summarized evidence for this assumption by comparing several states 
characterized by reduced levels of consciousness, including sleep, vegetative state, epilepsy, 
and anesthesia. They found lowered PCC activity in terms of decreased glucose metabolism to 
be a common feature of reduced levels of consciousness. Delta and theta oscillations are well 
known - amongst other things - for enacting inhibitory functions on cognitive and sensory 
processes (see also Harmony 2013; Knyazev 2007) by rhythmically decreasing the excitability 
of local groups of neuronal networks (Lakatos 2008). Moreover, a study in rats showed GHB 
to induce theta-range oscillatory hyperpolarizations (Williams 1995). Our data suggest that 
these slow oscillations emerge from the PCC. Theta oscillations located at the PCC are thought 
to have their origin in the dorsal hippocampus, mostly because of the phase reversal of theta 
occurring only in the hippocampus and are subsequently volume-conducted to the PCC (Talk 
2004). As maximal high-affinity binding on GABAB receptors was found in hippocampus 
(Maitre 1997) and this region has been shown to produce theta rhythms depending on 
GABAergic neurotransmission (Konopacki et al. 1997, Leung & Shen 2007), it is not surprising 
to find the modulatory effect of GHB on neuronal oscillations to be most pronounced at this 
region, which is closely linked by multiple direct and indirect routes (Myashita & Rockland 
2007). The absence of altered oscillatory activity regarding the hippocampus could probably be 
best explained by the complex cyto-architecture of this region, possibly resulting in a 
cancellation of opposing neuronal structures. Moreover, the thalamus is known to generate low 
frequency oscillations via GABAergic inhibition (Kim et al. 1997). The solution space of 
eLORETA does not include thalamic structures. Therefore, it is not possible to exclude the 
possibility of an additional involvement of the thalamus in generating the observed patterns in 
the present study (Pascual-Marqui et al. 1994).  
Although we found a trend in the direction of increased strength of functional 
connections after the intake of GHB, significance was not reached when contrasting the drug 
effect with placebo. When considering the trade-off between exhibiting sufficient statistical 
power to detect a plausible effect and the possibility of identifying a wide range of altered 
connections across the brain, we opted for a whole-brain approach that reduced the chances of 
observing small to moderate effects. From our perspective, the evidence in the literature was 
not strong enough to justify focusing solely on a subset of regions, or using one-tailed test 
statistics. An additional limitation for detecting supposedly small changes in functional 
connectivity could have been induced by the similarity in blood plasma measures between the 
administered dosage levels. Consequently, statistical significance was reached when the drug 
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effect on lagged phase synchronization was correlated with GHB plasma values. Most 
interestingly, this effect was found on connectivity between the inferior parietal lobule and the 
PCC, two major nodes within the DMN. When monitoring DMN connectivity during the 
different stages from wakefulness to sleep, previous research found it to be decreased drastically 
after losing consciousness (Sämann et al. 2011; Horovitz et al. 2009). Additionally, De Havas 
(2011) found DMN connectivity to be decreased after 24 hours of sleep deprivation and Bosch 
et al. (2013) found decreased PCC to ACC connectivity after partial sleep deprivation. When 
considering the role of lowered PCC glucose metabolism as well as decreased DMN 
connectivity as a neuronal correlate for reduced levels of consciousness, an interesting 
explanation for the pattern of “paradoxical EEG-behavioral dissociation” can be proposed: it is 
possible that the inhibitory function of slow waves on cognitive and sensory functions (see also 
Harmony 2013; Knyazev 2007) does not necessarily result in a loss of consciousness, as long 
as the requisite level of functional connectivity between the PCC and other nodes within the 
DMN can be maintained. Therefore, the interplay between slow, inhibitory oscillations 
generated at the PCC and the stable (or even slightly increased) connectivity of the DMN could 
be responsible for producing the unique electrophysiological profile of GHB at low to moderate 
doses, characterized by states that resemble loss of consciousness (reflected in the emergence 
of low frequency oscillations), without being reflected on a behavioral level.  
Additionally, Stamatakis and colleagues (2010) expected changes in connectivity 
between nodes of the default mode network (DMN) when sedating participants with different 
dosages of propofol, but found increased connectivity between the PCC and areas that are not 
widely reported to be synchronized with the DMN. This effect was correlated with increasing 
dosages of the anesthetic agent. Our data showed – at a trend level – that the score on the 
subscale “stimulation” was negatively correlated with the strength of the connection between 
the PCC and the fusiform gyrus regarding delta oscillations. Thus, we were able to add further 
evidence to support the assertion that heightened functional connectivity of the PCC with 
regions normally not implicated in the DMN could serve as a neuronal correlate of sedation. 
The global omega complexity index significantly differed between GHB and placebo 
when focusing on alpha oscillations. Remarkably, theta oscillations also seem to be affected at 
a trend level. In general, our finding of decreased omega complexity after the administration of 
GHB reflects a decreased number of relatively independent neural processes. Accordingly, a 
low number of independent processes indicate a high degree of neuronal synchronization and 
are therefore predictive for functional connectivity indices (Kondakor et al. 1999). However, 
the global omega complexity index can serve as a single, global marker for information 
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processing complexity and therefore adds further degrees of freedom for the interpretation of 
the results. Moreover, when correlating the drug effect on global omega complexity with GHB 
plasma values, significance was not reached. One explanation for the absence of the expected 
correlation could be that minor changes in blood plasma are sufficient to produce an effect of 
GHB on global omega complexity, such that it does not alter in a dose-dependent fashion. 
However, a more plausible explanation implies a highly localized effect of GHB, which is not 
necessarily reflected in a global index of omega complexity. This hypothesis receives further 
support from analysis of current source density, where we found changes limited to the 
cingulate cortex. 
Our results concerning global omega complexity correspond somewhat with the theory 
of the entropic brain (Carhart-Harris et al. 2014). The global omega complexity index can be 
associated to the concept of entropy. High complexity values reflect high entropy in numerous 
localised areas across the brain (Friston et al. 1995). Therefore, the observed decrease in 
complexity could be associated with a low entropic state of the brain. Carhart-Harris et al. 
(2014) proposed the theory of the entropic brain in order to explain qualities of different states 
of consciousness in terms of varying degrees of entropy. High entropic states, as seen for 
example after administration of the hallucinogen psilocybin, are opposed to low entropic states 
that can be observed in strongly sedated or anesthetized humans. Accordingly, during the last 
decade, entropy monitoring became a standard method for evaluating the depth of anesthesia 
(Jordan et al. 2008; Olofson et al. 2008). Moreover, this theory further characterizes high 
entropic states in terms of a decrease in alpha power of signals located at the PCC. The observed 
increase in alpha power after the administration of GHB (though only partially located at the 
PCC) suggests additional relevance for lowered states of consciousness, characterized by low 
entropy. 
After oral doses of 25 mg/kg and 35 mg/kg the VAS scores showed a strong general 
drug effect and significantly increased sedation. We were able to replicate the “paradoxical 
EEG-behavioral dissociation” reported in earlier studies after the administration of GHB in 
awake human subjects. Moreover, changes in current source density suggested theta oscillations 
emerging from the PCC to play a crucial role in producing the unique pharmacological profile 
of GHB. Our results give rise to a possible explanation regarding the paradoxical absence of 
convergence between electrophysiology and behavior. Namely, the increased slow oscillatory 
activity of the PCC seems to be a primary mechanism by which GHB alters electrophysiological 
patterns at the scalp surface, in a manner usually observed in states of drastically reduced levels 
of consciousness. Because of the stable or even slightly increased DMN connectivity induced 
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by GHB, such inhibitory functions could be compensated for and thereby may not be observable 
at a behavioral level, as would otherwise be expected when considering the shift towards lower 
frequencies after the administration of GHB. Additionally, analysis of global omega complexity 
following the administration of GHB was used to characterize common neuronal correlates of 
induced sedation, similar to other anesthetic compounds and akin to low entropic states.  
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Tables 
 
  
Table 1 
Table of F-values (degrees of freedom) derived from repeated measures ANOVA for all 
items of the VAS and GHB blood plasma levels with “drug” and “time” as factors. 
 
F value(df) 
“drug“ 
F value(df) 
“time“ 
F value(df) 
“drug * time“ 
Residual sum 
 squared 
VAS     
general drug effect 30.39(1)*** 13.29(5)*** 4.73(5)** 387.83 
sedation 23.08(1)*** 7.47(5)*** 3.45(5)* 518.20 
stimulation 6.00(1) 5.83(5)*** 2.92(5) 468.79 
dizziness 17.37(1)*** 6.90(5)*** 5.97(5)*** 218.56 
GHB     
Blood plasma 237.92(2)*** 47.75(5)*** 27.32(10)*** 37956 
Note. * p < .05, ** p < .01, *** p < .001. All p-values are corrected for multiple comparisons. 
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Supplement	
	
Preprocessing. EEG data were bandpass-filtered from 0.5-48 Hz in order to attenuate 
channel drifts and satisfying the stationary assumption necessary for computing 
independent component analysis (ICA) (Onton and Makeig 2006). The whole 
artefact-rejection procedure was performed using the Brain Vision Analyzer 2 
software (Brain Products GmBH). First, a trained researcher manually inspected all 
raw datasets in order to remove epochs that were obviously contaminated by sweat, 
technical, or muscle artefacts. Second, an infomax ICA was performed removing eye 
blinks as well as vertical and horizontal eye movements (Bell and Sejnowski 1995; 
Lee and Seung 1999). Third, channels with bad data quality were interpolated using 
spherical splines (Perrin, Pernier, Bertrand, and Echallier 1989). Forth, the complete 
data was re-referenced to the average of all electrodes. Fifth, the artefact-free parts 
were segmented in epochs with a length of two seconds each. Last, a repeated 
measure ANOVA with the factors placebo vs. GHB and eyes-open vs eyes-closed 
was applied in order to test whether the number of artefact free segments differ 
between the conditions. All contrasts remained non-significant (p > .05). 
 
  
	
Suppl.	Fig.	1	Statistical	map	of	voxel‐wise	comparisons	of	current	source	density	
for	all	frequency	bands	in	the	eyes	open	condition.	The	threshold	for	this	
condition	was	adjusted,	therefore	red	depicts	highest	voxel	values	that	remained	
non‐significant	(p	>	.05,	corrected).	
